The AML stock had a very optimistic rally before Christmas.
Although, vaccination's progressing at a decent pace, keeping the stock (and market) hot, the reality will creep in as indicated by a chart pattern.
I always look behind the scene to get a better idea of risk / reward and atm I don't see any solid "buys" here. Most likely we'll find support at 50p (£10) in the near future.
Split & consolidation in one year, what's it all about?
OK, the former action which took place in March was, perhaps, a necessity but I'm not convinced about the latter. Will it reduce the liquidity of the stock? (Please share your thoughts in the comments) What about the psychological barrier? Do you have a feeling that the stock is "too expensive"?